Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Härle P et al. - It is possible to detect PsA patients in a dermatologic outpatient setting with the GEPARD questionnaire.

Exclusive Author Commentary
P. Härle, 05/28/09

Detection of arthritis in psoriasis individuals is often delayed. Furthermore, as with rheumatoid arthritis, it seems difficult to detect PsA at an early manifestation time. The GEPARD-Questionnaire is answered soley by the patient with psoriasis himself in the waiting area of the dermatology practice. This gives us the chance to detect PsA, at earlier manifestation times, without further time-consuming work-up for the dermatologist, and the great chance to intensify the cooperation between deramtologists and rheumatologists. This is especially important, for additional systemic therapy of Ps and PsA making successful treatment more likely. However, systemic side-effects, like infections, are becoming more and more an issue were rheumatologists and dermatologists need to work together more closely in order to give the best care and safety to the patient.

Today in Other Arthritis...keeping you current

Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
Open Access Rheumatology: Research and Reviews, 12/10/09

Clinical features and functional significance of the P369S/ R408Q variant in pyrin, the familial Mediterranean fever protein
Annals of Rheumatic Diseases, 12/10/09

Synovial immunopathology in hemochromatosis arthropathy
Annals of Rheumatic Diseases, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address